A comparative study of mutation screening of sarcomeric genes (MYBPC3, MYH7, TNNT2) using single gene approach versus targeted gene panel next generation sequencing in a cohort of HCM patients in Egypt

[1]  F. Liu,et al.  Characterization of the late embryogenesis abundant (LEA) proteins family and their role in drought stress tolerance in upland cotton , 2018, BMC Genetics.

[2]  S. Cook,et al.  Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes , 2017, European heart journal.

[3]  D. MacArthur,et al.  Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples , 2016, Genetics in Medicine.

[4]  E. Coto,et al.  Spectrum of Mutations in Hypertrophic Cardiomyopathy Genes Among Tunisian Patients. , 2016, Genetic testing and molecular biomarkers.

[5]  S. Cook,et al.  Development of a Comprehensive Sequencing Assay for Inherited Cardiac Condition Genes , 2016, Journal of Cardiovascular Translational Research.

[6]  Aleks,et al.  Ventilation disorders diagnosed preoperatively in patients scheduled for isolated on-pump CABG: Do they increase inflammatory response in the early postoperative period? , 2016 .

[7]  J. Krieger,et al.  Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy. , 2013, American heart journal.

[8]  P. Stenson,et al.  The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine , 2013, Human Genetics.

[9]  Jingang Yang,et al.  Mutation spectrum in a large cohort of unrelated Chinese patients with hypertrophic cardiomyopathy. , 2013, The American journal of cardiology.

[10]  Claudia Giambartolomei,et al.  Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing , 2013, Journal of Medical Genetics.

[11]  Madhuri Hegde,et al.  Assessment of clinical analytical sensitivity and specificity of next-generation sequencing for detection of simple and complex mutations , 2013, BMC Genetics.

[12]  Chan-na Zhang,et al.  Multiple gene mutations, not the type of mutation, are the modifier of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy , 2013, Molecular Biology Reports.

[13]  M. Yacoub,et al.  Early Results of Sarcomeric Gene Screening from the Egyptian National BA-HCM Program , 2012, Journal of Cardiovascular Translational Research.

[14]  Despina Sanoudou,et al.  Molecular genetics made simple , 2012, Global cardiology science & practice.

[15]  M. Isobe,et al.  Prevalence and distribution of sarcomeric gene mutations in Japanese patients with familial hypertrophic cardiomyopathy. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[16]  S. Temtamy,et al.  Consanguinity and genetic disorders in Egypt , 2012 .

[17]  Robert A. Edwards,et al.  Quality control and preprocessing of metagenomic datasets , 2011, Bioinform..

[18]  R. Porcher,et al.  Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy. , 2010, European journal of medical genetics.

[19]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[20]  Daniel Rios,et al.  Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor , 2022 .

[21]  Aaron R. Quinlan,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2022 .

[22]  J. Towbin,et al.  Diagnostic, Prognostic and Therapeutic Implications of Genetic Testing for Hypertrophic Cardiomyopathy , 2010 .

[23]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[24]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[25]  María P. Martín,et al.  Espectro mutacional de los genes sarcoméricos MYH7, MYBPC3, TNNT2, TNNI3 y TPM1 en pacientes con miocardiopatía hipertrófica , 2009 .

[26]  V. Álvarez,et al.  [Mutations in sarcomeric genes MYH7, MYBPC3, TNNT2, TNNI3, and TPM1 in patients with hypertrophic cardiomyopathy]. , 2009, Revista espanola de cardiologia.

[27]  Rachael,et al.  Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. , 2008, Mayo Clinic proceedings.

[28]  F. Girolami,et al.  A molecular screening strategy based on β-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy , 2006, Journal of cardiovascular medicine.

[29]  Y. Zhen,et al.  Mutations profile in Chinese patients with hypertrophic cardiomyopathy. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[30]  A. Tajik,et al.  Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[31]  A. Tajik,et al.  Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[32]  V. Regitz-Zagrosek,et al.  Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy , 2003, Clinical genetics.

[33]  Erik G. Ellsworth,et al.  Prevalence and Spectrum of Thin Filament Mutations in an Outpatient Referral Population With Hypertrophic Cardiomyopathy , 2003, Circulation.

[34]  M. Komajda,et al.  Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy , 2003, Circulation.

[35]  M. Yacoub,et al.  Genomic organisation, alternative splicing and polymorphisms of the human cardiac troponin T gene. , 1998, Journal of molecular and cellular cardiology.

[36]  M. Komajda,et al.  Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. , 1997, Circulation research.

[37]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[38]  Wigle Ed.  Novel insights into the clinical manifestations and treatment of hypertrophic cardiomyopathy. , 1995 .

[39]  E. Wigle.  Novel insights into the clinical manifestations and treatment of hypertrophic cardiomyopathy. , 1995, Current opinion in cardiology.